Showing 1 - 20 results of 216 for search '"bladder cancer"', query time: 0.08s Refine Results
  1. 1

    Bladder Cancer by A. Karim Kader

    Published 2011-01-01
    Get full text
    Article
  2. 2
  3. 3

    Superficial Bladder Cancer Therapy by Emmanuel Schenkman, Donald L. Lamm

    Published 2004-01-01
    “…Bladder cancer treatment remains a challenge despite significant improvements in preventing disease progression and improving survival. …”
    Get full text
    Article
  4. 4

    A model of thermotherapy treatment for bladder cancer by Christoph Sadée, Eugene Kashdan

    Published 2016-07-01
    Subjects: “…bladder cancer…”
    Get full text
    Article
  5. 5
  6. 6

    Recognition and Treatment of BCG Failure in Bladder Cancer by Andrew J. Lightfoot, Henry M. Rosevear, Michael A. O'Donnell

    Published 2011-01-01
    “…Patients with high-grade Ta, T1, or carcinoma in situ non–muscle-invasive bladder cancer (NMIBC) are at high risk for recurrence and, more importantly, progression. …”
    Get full text
    Article
  7. 7
  8. 8

    Urothelial Bladder Cancer with Cavitary Lung Metastases by Anil Kurian, Jason Lee, Abraham Born

    Published 2011-01-01
    “…Long-term survival of patients with metastatic bladder cancer is rare. Patterns of pulmonary metastasis include multiple nodules, a solitary mass or interstitial micronodule. …”
    Get full text
    Article
  9. 9

    COMBINED TREATMENT OF LOCALLY-ADVANCED BLADDER CANCER by I. V. Chernyshev, Y. V. Samsonov, D. V. Perepechin, A. M. Ulbashev

    Published 2016-01-01
    Subjects: “…locally advanced bladder cancer…”
    Get full text
    Article
  10. 10

    Epigenetic Alterations in Bladder Cancer and Their Potential Clinical Implications by Han Han, Erika M. Wolff, Gangning Liang

    Published 2012-01-01
    “…Urothelial carcinoma (UC), the most common type of bladder cancer, is one of the most expensive malignancies to treat due to its high rate of recurrence. …”
    Get full text
    Article
  11. 11
  12. 12

    Management of Bladder Cancer following Solid Organ Transplantation by Jeffrey J. Tomaszewski, Jeffrey A. Larson, Marc C. Smaldone, Matthew H. Hayn, Stephen V. Jackman

    Published 2011-01-01
    “…Present our experience managing bladder cancer following liver and renal transplantation. …”
    Get full text
    Article
  13. 13
  14. 14

    The Use of Regenerative Medicine in the Management of Invasive Bladder Cancer by Matthew E. Hyndman, Deborah Kaye, Nicholas C. Field, Keith A. Lawson, Norm D. Smith, Gary D. Steinberg, Mark P. Schoenberg, Trinity J. Bivalacqua

    Published 2012-01-01
    “…Muscle invasive and recurrent nonmuscle invasive bladder cancers have been traditionally treated with a radical cystectomy and urinary diversion. …”
    Get full text
    Article
  15. 15
  16. 16

    Emerging Endoscopic and Photodynamic Techniques for Bladder Cancer Detection and Surveillance by Prashant Patel, Richard T. Bryan, D. Michael A. Wallace

    Published 2011-01-01
    “…This review provides an overview of emerging techniques, namely, photodynamic diagnosis (PDD), narrow band imaging (NBI), Raman spectroscopy, optical coherence tomography, virtual cystoscopy, and endoscopic microscopy for its use in the diagnosis and surveillance of bladder cancer. The technology, clinical evidence and future applications of these approaches are discussed with particular emphasis on PDD and NBI. …”
    Get full text
    Article
  17. 17
  18. 18

    Role of Re-Resection in Non–Muscle-Invasive Bladder Cancer by Harry W. Herr

    Published 2011-01-01
    “…Restaging, or second transurethral resection (TUR), is essential to successful management of high-risk, non–muscle-invasive bladder cancer. Here we review the relevant literature documenting the role of restaging TUR. …”
    Get full text
    Article
  19. 19
  20. 20

    The Role of the Surgeon and Transurethral Resection in the Treatment of Superficial Bladder Cancer by Alan M. Nieder, Murugesan Manoharan

    Published 2006-01-01
    “…Non-muscle invasive bladder cancers are a heterogeneous group of cancers whose spectrum includes low grade Ta lesions and high-grade T1 lesions. …”
    Get full text
    Article